Table 1 Characteristics of the study population
|  | Missing | All (N = 658) |
|---|---|---|
Male, n, % | 0 | 478 (72%) |
Age, ± SD | 0 | 61 ± 15 |
Charlson comorbidities index, median [IQR] | 0 | 2 [1–4] |
Home location, n, % | 0 | 423 (64%) |
Witness, n, % | 0 | 566 (86%) |
Bystander CPR, n, % | 0 | 449 (68%) |
Occurrence of cardiac arrest after EMS arrival, n, % | 0 | 88 (13%) |
Shockable rhythm, n, % | 0 | 318 (48%) |
No flow duration, min, median [IQR] | 0 | 3 [0–8] |
Low flow duration, min, median [IQR] | 0 | 20 [15–30] |
Time to 911, min, median [IQR] | 0 | 10 [5–15] |
Epinephrine use, n, % | 0 | 491 (75%) |
Epinephrine dose, mg, median [IQR] | 0 | 2 [0–4] |
First arterial pH, ± SD | 9 | 7.26 [7.14–7.35] |
Post resuscitation shock, n, % | 1 | 355 (54%) |
ST elevation, n, % | 3 | 225 (34%) |
Early invasive coronary strategy, n, % | 26 | 351 (56%) |
Cardiac cause as supposed origin of arrest, n, % | 3 | 422 (64%) |
Targeted temperature management between 32° to 36 °C, n, % | 0 | 568 (86%) |
Survival at ICU discharge, n, % | 0 | 249 (38%) |
Survival at day 90, n, % | 0 | 241 (37%) |
Favorable functional outcome at day 90, n, % mRS 3–2–1–0 | 0 | 223 (34%) |